MYO1F and neoplasm: Most of the 63 differentially expressed genes identified by TME-score, such as ARHGDIB, MYO1F,and CD14 have been demonstrated to facilitate tumor proliferation and regulate tumor immune microenvironment in breast (41) and pancreatic (42) cancers, respectively.